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P2X receptors are trimericATP-gatedcation channels
involved in physiological processes ranging widely
from neurotransmission to pain and taste signal
transduction. The modulation of the channel gating,
including thatbydivalent cations, contributes to these
diverse physiological functions of P2X receptors.
Here,we report thecrystal structureof an invertebrate
P2X receptor from the Gulf Coast tick Amblyomma
maculatum in the presence of ATP and Zn2+ ion,
together with electrophysiological and computational
analyses. The structure revealed two distinct metal
binding sites, M1 and M2, in the extracellular region.
TheM1 site, located at the trimer interface, is respon-
sible for Zn2+ potentiation by facilitating the structural
change of the extracellular domain for pore opening.
In contrast, theM2 site, coupled with the ATP binding
site, might contribute to regulation by Mg2+. Overall,
our work provides structural insights into the divalent
cation modulations of P2X receptors.INTRODUCTION
P2X receptors are trimeric cation channels that respond to extra-
cellular ATP and play a crucial role in initiating extracellular
ATP signaling (Brake et al., 1994; Chen et al., 1995; Valera
et al., 1994). In vertebrates, the seven subtypes of P2X receptors
form homo- or hetero-trimers, with each protomer consisting
of two transmembrane helices and a large, hydrophilic extracel-
lular domain (North, 2002). The transmembrane domain is
responsible for the formation of a non-selective cation pore,
whereas the extracellular domain includes binding sites for
ATP, regulatory metal ions, and antagonists (Egan et al., 2006).
P2X receptors exhibit various biophysical and pharmacological932 Cell Reports 14, 932–944, February 2, 2016 ª2016 The Authorsproperties and are widely expressed in the human body. Accord-
ingly, P2X receptors are involved in diverse physiological
processes, such as muscle contraction, neurotransmission, in-
flammatory response, and pain and taste signal transduction
(Khakh andNorth, 2012; Surprenant andNorth, 2009). Therefore,
they are associated with numerous human diseases, including
chronic inflammatory and neuropathic pain, depression, and
cancer (Burnstock, 2006; Burnstock and Ralevic, 2014; Gever
et al., 2006; North and Jarvis, 2013).
The activation of ligand-gated ion channels, including P2X re-
ceptors, Cys-loop receptors, and ionotropic glutamate recep-
tors, is modulated by various molecules to diversify their physio-
logical functions (Jarvis and Khakh, 2009; Miller and Smart,
2010; Traynelis et al., 2010). In particular, divalent cations are
important regulatory factors in these ion channel superfamilies.
For instance, in some P2X receptors, such as the P2X2 and
P2X4 receptors, a Zn2+ ion potentiates the ATP-dependent cur-
rents (Garcia-Guzman et al., 1997; Nakazawa and Ohno, 1997;
Se´gue´la et al., 1996; Soto et al., 1996). The Zn2+ modulation of
P2X4 receptors may play a role in the enhancement of long-
term potentiation (Lorca et al., 2011) and insulin secretion (Ri-
chards-Williams et al., 2008).
The recently determined structures of the zebrafish P2X4
(zfP2X4) receptor in the apo, closed state and the ATP-bound,
open state provided the structural framework for trimer forma-
tion, ATP recognition, and ATP-dependent activation in the
P2X receptor family (Hattori and Gouaux, 2012; Jiang et al.,
2013; Kawate et al., 2009; Samways et al., 2014). The subse-
quent structure-based electrophysiological and computational
analyses provided further clarification of the activation mecha-
nism of P2X receptors (Heymann et al., 2013; Lo¨rinczi et al.,
2012; Roberts et al., 2012; Zhao et al., 2014). However, the mo-
lecular mechanisms of the divalent cation modulation of the P2X
receptors, underlying the diversity of the receptor functions,
have still proved elusive.
P2X receptors have also been cloned from invertebrate species
(Agbohetal., 2004;Bavanetal., 2009;Bavanetal., 2012;Fountain
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Figure 1. Functional Properties of AmP2X and Crystallization Construct AmP2Xcryst
(A) FSEC profiles on a Superdex 200 10/300GL column (GEHealthcare) for the EGFP-fused AmP2XWT (black), the EGFP-fused AmP2Xcryst (blue), and the EGFP-
fused zfP2X4WT (red), expressed in HEK293T cells. The arrows indicate the estimated elution positions of the void volume, the EGFP-fused P2X (trimer), and the
free EGFP.
(B) Representative currents of the AmP2X WT evoked by 100 mM ATP.
(C) Representative current traces of AmP2Xcryst with the application of 100 mM ATP, showing no evoked current.
(D) Measurement of the ATP binding ability of the EGFP-fused AmP2Xcryst by a
3H-ATP binding assay. Error bars indicate ±SEM for triplicate samples. The
calculated Kd for
3H-ATP binding is 0.745 ± 0.238 mM.et al., 2007; Raouf et al., 2005). They share low sequence identity
with their vertebrate counterparts and seem to represent ortho-
logs to ancestral P2X receptors. Like their vertebrate counter-
parts, the invertebrate P2X receptors function as ATP-gated,
non-selective cation channels, and their biophysical properties
include divalent cationmodulations. Accordingly, the invertebrate
P2X receptors can be a useful model for structural and electro-
physiological studies to clarify the molecular mechanisms of the
divalent cation modulations of the vertebrate P2X receptors.
Here we report the crystal structure of the P2X receptor from
the Gulf Coast tick, Amblyomma maculatum (AmP2X), an inver-
tebrate harboring one copy of the P2X receptor gene. Together
with electrophysiological and computational analyses, our study
provides structural insights into the divalent cation modulations
of P2X receptors.CRESULTS
Functional Characterization and Structure
Determination of AmP2X
Fluorescence-detection size-exclusion chromatography (FSEC)
of an N-terminally GFP-tagged P2X receptor from AmP2X
showed a sharp, symmetrical profile (Kawate and Gouaux,
2006), comparable to that of the zfP2X4 receptor with its known
crystal structures (Hattori and Gouaux, 2012; Kawate et al.,
2009), indicating that AmP2X is a promising target for structural
analysis (Figure 1A). The two-electrode voltage clamp (TEVC)
recording of Xenopus oocytes expressing AmP2X revealed
that AmP2X functions as an ATP-gated cation channel with
fast inactivation, or in other words, desensitization (Figure 1B),
while the amino acid sequence of AmP2X is most closely relatedell Reports 14, 932–944, February 2, 2016 ª2016 The Authors 933
to that of the slowly desensitizing P2X4 receptor among the
mammalian P2X receptors (40% sequence identity) (Figures
S1 and S2). In addition, a huge current decline occurred in the
AmP2X-current amplitude, in response to the second and sub-
sequent ATP applications, even after a 10 min interval (Fig-
ure 1B). This shows the strong channel rundown in the AmP2X
receptor. Channel rundown has been reported for other P2X re-
ceptors, such as P2X1, P2X3, P2X5, and some mutant P2X re-
ceptors, as well as for other ligand-gated ion channels (Bo
et al., 2000; Fujiwara and Kubo, 2006; Jensik and Cox, 2002;
Lewis and Evans, 2000; Mo et al., 2009). It is typically caused
by slow recovery from inactivation or channel internalization,
as observed in other P2X receptors (Bernier et al., 2008; Fujiwara
and Kubo, 2006; Jensik and Cox, 2002; Mo et al., 2009).
To further investigate this channel property of AmP2X, we con-
ducted simultaneous fluorescent imaging and electrical record-
ings of Xenopus oocytes expressing GFP-tagged AmP2X recep-
tors (Figure S3). The results showed that wild-type (WT) AmP2X
was expressed at the cell surface and repetitive ATP applica-
tions did not induce the internalization of AmP2X (Figure S3A),
indicating that fast inactivation and slow recovery from inactiva-
tion caused the strong channel rundown of AmP2X.
The removal of 23 N-terminal and 7 C-terminal residues and
the mutations of Asn171 and Cys374 (AmP2Xcryst, DN23/DC7/
N171Q/C374L) yielded crystals diffracting up to 2.8 A˚ resolution
in the presence of ATP and Zn2+ ion (Table S1). The deletion of 23
N-terminal and 7 C-terminal residues was designed basically ac-
cording to the zfP2X4-C crystallization construct of zfP2X4 (Hat-
tori and Gouaux, 2012). C374L was designed to remove the free
cysteine residue to avoid non-specific disulfide formation.
Asn171, a putative glycosylation site, was mutated to reduce
the heterogeneity of the construct for crystallization. Although
AmP2Xcryst still exhibited ATP binding activity and cell surface
expression (Figures 1D and S3B), it did not show ATP-depen-
dent gating activity (Figure 1C). The structure of AmP2Xcryst
was solved by molecular replacement, using the ATP-bound
zfP2X4 structure as the search model (Figures S4A–S4C).
Overall Structure and ATP Binding Site
AmP2Xcryst adopts a chalice-like trimeric architecture, and each
subunit of AmP2Xcryst consists of a large extracellular domain
and two transmembrane helices resembling the shape of a dol-
phin, as observed in the zfP2X4 structure (Figures 2A, 2B, and
S4D) (Hattori and Gouaux, 2012; Kawate et al., 2009). We
observed strong electron density peaks corresponding to ATP
molecules at each subunit interface of the extracellular domain
(Figure 2C), consistent with the crystallization conditions con-
taining 1 mM ATP and the ATP binding activity of the AmP2Xcryst
construct (Figure 1D). The ATP molecules adopt a bent confor-
mation and form tight interactions with the receptor (Figure 2C).
The phosphate groups are recognized by the side chains
of Lys66, Lys68, and Lys210 from one subunit and Asn311,
Arg313, and Lys327 from the neighboring subunit, whereas the
adenine ring of ATP forms hydrogen bonds with the side chain
of Thr206 and the main chain carbonyl atoms of Lys66 and
Thr206 (Figure 2C). All of these hydrophilic residues are highly
conserved among P2X receptors (Figure S1) and are important
for their ATP-dependent gating activities (Ennion et al., 2000;934 Cell Reports 14, 932–944, February 2, 2016 ª2016 The AuthorsJiang et al., 2000; Marquez-Klaka et al., 2007; Roberts et al.,
2008; Roberts and Evans, 2004, 2006, 2007).
While the extracellular domain structure of AmP2Xcryst resem-
bles that of the ATP-bound, open zfP2X4, rather than that of apo,
closed zfP2X4 (Figure S4E), the transmembrane domain of
AmP2Xcryst exhibits a unique feature. The root-mean-square de-
viations (RMSDs) for the 138 Ca atoms from the transmembrane
domain of the trimer are 2.2 A˚ between AmP2X and ATP-bound
zfP2X4 and 4.9 A˚ between AmP2X and apo, closed zfP2X4
(Figures 2E, 2F, and 3A–3C). Thus, the structure of the trans-
membrane domain of the AmP2X trimer is closer to that of
ATP-bound, open zfP2X4 (Figures 2E, 2F, and 3A–3C). In
contrast, the transmembrane domain of each AmP2X monomer
resembles that of the apo, closed state of zfP2X4 (Figures 2D
and 3J–3L). The RMSDs for the 46Ca atoms from the transmem-
brane domain of each monomer are 2.1 A˚ between AmP2X and
ATP-bound zfP2X4 and 1.7 A˚ between AmP2X and apo, closed
zfP2X4.
The superimposition of the transmembrane architecture of
AmP2Xcryst with those of the previously determined zfP2X4
structures revealed further details about their structural differ-
ences. Consistent with the ATP-dependent expansion of the
extracellular domain, the TM1 and TM2 helices in the AmP2Xcryst
structure are rotated by 5 and 40 degrees counterclockwise
around the pore-center axis, relative to the closed state, whereas
those in the ATP-bound zfP2X4 are rotated by 10 and 55
degrees counterclockwise around the pore-center axis, respec-
tively (Figure 2F). These movements induce an iris-like expan-
sion of the transmembrane helices by 3 A˚ to form a pore (Fig-
ures 3A–3C). Consistent with the smaller rotation angles, the
pore size at the constriction region is smaller in the AmP2Xcryst
structure (Figures 3D–3I). The TM2 helices are totally straight in
the AmP2Xcryst structure, which restricts the wide pore formation
(Figures 3B, 3E, 3H, 3K, and 3N), while the kink of TM2 at the
highly conserved Gly350 residue in zfP2X4 enables the TM2 he-
lices to form the larger pore (Figures 3C, 3F, 3I, 3L, and 3O). In
AmP2X, the residue corresponding to Gly350 in zfP2X4 is re-
placed by Val (Figure S1). Overall, the ion-conducing pore is
partially opened in the AmP2Xcryst structure with the straight
TM2 helices.
Because the ion-conducting pore is partially opened, the pre-
sent structure of AmP2Xcryst might reflect either a pre-open state
before channel opening or an inactivated state after channel
opening. Considering the loss of the channel gating activity
and the structural features, including the activated extracellular
domain (Figures 1D and S4E), we regard the pre-open state, in
which an ATP-induced conformational change in the extracel-
lular cellular domain is partially propagated to the transmem-
brane domain, to be more likely.
Furthermore, it was proposed that the transmembrane archi-
tecture of the previously determined ATP-bound structure of
the zfP2X4 trimer, including the large inter-subunit gaps, is
partially distorted from that in the membrane-embedded native
state (Heymann et al., 2013). Because the trimeric architecture
of AmP2Xcryst resembles that of the ATP-bound structure of
zfP2X4 (Figures 3E and 3F), similar inter-subunit gaps are
observed in the transmembrane region of the trimeric AmP2Xcryst
structure (Figure 3E). Accordingly, we do not exclude the
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Figure 2. Overall Structure and ATP Binding Sites
(A) The ATP-bound AmP2Xcryst structure viewed parallel to the membrane. The omit Fo  Fc map contoured at 4s, showing the electron density of the ATP.
(B and C) Close-up view of the ATP binding site in the ATP-bound AmP2Xcryst. The amino acid residues and ATP are depicted by stick models. The molecule is
colored according to the dolphin-like model. Dotted black lines (C) indicate hydrogen bonds (<3.3 A˚).
(D) Structural transition in the transmembrane helices. The transmembrane helices of the ATP-bound AmP2Xcryst (red) are superimposed on those of apo, closed
DP2X4-B2 (gray) and of ATP-boundDP2X4-C (blue) using the Ca positions of residues 32–51 and 345–370 for AmP2X and residues 36–55 and 334–359 for zfP2X4,
respectively. Gly350 in the two zfP2X4 structures and Val361 in the AmP2X structure are depicted by stick models.
(E and F) Structural comparison of the transmembrane domains as trimers viewed parallel to the membrane (E) and from the intracellular side (F). The trans-
membrane domain of the ATP-bound AmP2Xcryst (red) is superimposed as a trimer on those of apo, closed DP2X4-B2 (gray) and of ATP-bound DP2X4-C (blue)
using the Ca positions of residues 32–51 and 345–370 for AmP2X and residues 36–55 and 334–359 for zfP2X4, respectively. The black arrows and bars denote
the rotation of the transmembrane helices.possibility that the trimer formation of the transmembrane
domain in the AmP2Xcryst structure is also partially distorted,
possibly because of detergents or truncations employed for
crystallization.
Zn2+ Binding Site and Modulation
In the ATP-bound AmP2Xcryst structure crystallized in the pres-
ence of Zn2+ ion, we observed strong residual electron densities
at two distant sites in the extracellular domain (Figure 4A). The
anomalous difference Fourier map clearly showed that these
densities correspond to Zn2+ ions (Figures 4B–4D). Accordingly,
we identified two distinct metal binding sites in the extracellular
domain of AmP2Xcryst and named them theM1 andM2 sites. The
M1 site is located at the trimer interface at the top part of the up-
per body domain of the dolphin model, in other words, the cen-
tral chamber region (Figure 4A), and is coordinated by the side
chains of Glu105 in one subunit and Glu106 in the neighboringCsubunit (Figures 4C and 4D). Among the P2X4 receptors, the cor-
responding residues at the M1 site are strictly conserved as Gln
andGlu residues, respectively (Figure S1). TheM2 site is coupled
with the ATP binding site, and is surrounded by the side chain of
Asp188 and the g-phosphate group of ATP, to bridge the recep-
tor and ATP molecules (Figure 4B). Asp188 is strictly conserved
among the P2X1 and P2X3 receptors (Figure S1).
To investigate the functional roles of these metal binding sites,
we first conducted structure-based electrophysiological ana-
lyses of Zn2+ potentiation. Because a huge current decline
occurred in the AmP2X-current amplitudes, in response to the
second and subsequent ATP applications (Figure 1B), AmP2X
would not be suitable to analyze the Zn2+ potentiation by
repetitive ATP applications. Therefore, we employed rat P2X4,
which has well-established electrophysiological properties,
including Zn2+ potentiation (Garcia-Guzman et al., 1997; Soto
et al., 1996). We created the mutants (rE95A, rD170A, andell Reports 14, 932–944, February 2, 2016 ª2016 The Authors 935
rE95A/rD170A) of rGlu95 and rAsp170 for the equivalent residues
in rat P2X4, corresponding to Glu106 in the M1 site and Asp188
in the M2 site of AmP2X, respectively (the superscript ‘‘r’’ refers
to rat P2X4). The mutation at the M1 site (rE95A) abolished the
potentiation effect of Zn2+ ion (Figures 5A and 5B), whereas
the mutation at the M2 site (rD170A) did not affect the Zn2+
potentiation of the ATP-dependent currents (Figures 5A and 5B).
Glu105 and Glu106 at the M1 site in AmP2X are conserved
as similar residues, Gln and Glu, respectively, among P2X4 re-
ceptors and some invertebrate P2X receptors (Figure S1). The
Gln and Glu pair in the M1 site of these receptors would also
provide chemically favorable conditions for Zn2+ binding, as
observed in the AmP2X structure (Figures 4C and 4D). Consis-
tently, our electrophysiological analysis revealed that the M1
site is responsible for the Zn2+ potentiation of the rat P2X4 re-
ceptor (Figures 5A and 5B). Furthermore, an invertebrate P2X
receptor, LsP2X from the great pond snail, Lymnaea stagnalis,
which possesses the M1 site (Figure S1), is also reportedly
potentiated by Zn2+ ion (Bavan et al., 2012). Overall, our results
suggest the functional role of the M1 site in zinc potentiation for
the P2X4 receptors and the invertebrate P2X receptors pos-
sessing the M1 site.
The M1 site is overlapped with or neighboring the previously
identified metal binding sites for Gd3+ and Mg2+ in the central
chamber region, which are implicated in the inhibition of P2X re-
ceptors (Figures 4E–4G) (Kawate et al., 2009; Li et al., 2013). The
M1 site shares some residues (rGlu95 in rat P2X4) with the Gd3+
binding site (zfGlu98 in zfP2X4) identified in the previously deter-
mined zfP2X4 structure in the apo, closed state (Figures 4E–4G)
(Kawate et al., 2009). The application of Gd3+ inhibited the ATP-
dependent activation of zfP2X4. Accordingly, the Gd3+ binding
site seemed to play an important role in Gd3+ modulation
(Kawate et al., 2009). However, we found that the mutation of
rGlu95 did not abolish the Gd3+-dependent inhibition (Figures
S5A–S5D). The addition of 1 mM Gd3+ ion to a 100 mM ATP
solution totally depleted the ATP because of precipitation (Fig-
ure S5E). Furthermore, the values of the Hill coefficients were
out of order (about <35), suggesting that GdCl3 does not affect
the specific binding reaction between the ATP and the P2X re-
ceptor. Therefore, the depletion of ATP by Gd3+ addition, rather
than the Gd3+ binding to the receptors, could be mainly respon-
sible for the inhibitory effect of Gd3+ on the ATP-dependent acti-
vation of P2X receptors. More importantly, the Thr87 residue in
the human P2X3 receptor, corresponding to Ser107 in AmP2X
and Asp99 in zfP2X4 (Figures 4F and 4G), is implicated in the
Mg2+-dependent inhibition (Li et al., 2013). The Thr87 residue
is located within the central chamber region and neighbors the
M1 site and the Gd3+ binding site (Figures 4A and 4C–4G).
Accordingly, the central chamber region in the extracellular
domain may provide multiple cation binding sites for both poten-
tiation and inhibition in P2X receptors.
Zn2+ Modulation Mechanism
To investigate how Zn2+ ion at the M1 site modulates channel
gating, we performed all-atommolecular dynamics (MD) simula-
tions of the ATP-bound AmP2Xcryst in the presence and absence
of Zn2+ at theM1 site (Figure 6). To analyze the initial early events
upon zinc binding in the zinc potentiation of P2X receptors, the936 Cell Reports 14, 932–944, February 2, 2016 ª2016 The AuthorsMD simulations were performed for 150 ns. We calculated the
radial distance r of the center axis, and the polar angle q and
the azimuthal angle f of the helical axis, to quantitatively esti-
mate the structural change in the transmembrane region (Figures
S4F and S4G) (Dai and Zhou, 2014). The results of the MD
simulations revealed higher radial distance r and greater polar
angle q in the presence of Zn2+ ion (Figures 6A–6C), indicating
that Zn2+ binding at the M1 site promotes channel opening (Fig-
ures 6D–6F). A further structural comparison of the extracellular
domain revealed how Zn2+ binding to the extracellular domain
facilitates channel opening in the transmembrane domain. First,
Zn2+ binding to the M1 site brings two glutamate residues,
Glu105 from one subunit and Glu106 from the neighboring sub-
unit, toward each other by electrostatic attraction (Figures 6G,
6H, and 6M). This attraction induces the small counterclockwise
rotation of the lower body domain by 2 degrees (Figure 6I),
whereas the side chains of the residues are turned away from
each other in the absence of Zn2 (Figures 6G, 6H, and 6K). The
Zn2+-dependent small structural change within the upper lower
body is magnified into the larger movement in the lower part of
the body domain, which is directly connected to the transmem-
brane domain. Accordingly, the transmembrane domain is
rotated counterclockwise by 10 degrees to open the pore
(Figures 6J and 6M).
Zn2+ potentiation has also been reported for the P2X2 recep-
tors (Wildman et al., 1998). Two histidine residues, His120 and
His213, in the rat P2X2 receptor are involved in the zinc potenti-
ation (Clyne et al., 2002; Nagaya et al., 2005) and are located at
the head and dorsal fin domains forming the ATP binding cleft
(Figures 2B, S1, and S4D), whereas these histidine residues
are not conserved among the P2X4 receptors (Figure S1). The
ATP binding causes the cleft closure motion in the ATP binding
pocket, which in turn induces the structural change of the
body domain for pore opening (Hattori and Gouaux, 2012; Jiang
et al., 2012). Accordingly, Zn2+ binding to these histidine
residues bridges the inter-subunit cleft within the ATP binding
pocket to facilitate channel activation (Jiang et al., 2012). In
contrast, the M1 site is located far from the ATP binding pocket
(Figures 4A, 4C, and 4D), and Zn2+ binding to the M1 site would
be directly coupled to the structural change of the body domain
for pore opening (Figure 6). Therefore, the molecular mechanism
of Zn2+ potentiation in P2X2 receptors is distinct from that in
P2X4 receptors.
Taken together, our results show that allosteric Zn2+ binding to
the M1 site facilitates the ATP-dependent structural change of
the body domain in the extracellular region for pore opening.
Putative Mg2+ Modulation Mechanism
We then investigated the possible function of the M2 site in the
modulations of P2X receptors by other divalent cations. While
ATP exists predominantly as the MgATP2 complex in vivo, a
recent electrophysiological analysis demonstrated that distinct
subtypes of P2X receptors exhibit differential sensitivities to
MgATP2, leading to modulation by Mg2+ (Li et al., 2013). The
fast-desensitizing P2X receptors, such as P2X1 and P2X3, can
be activated by both MgATP2 and Mg2+-free ATP with similar
efficacies (Li et al., 2013). In contrast, the slowly desensitizing
P2X receptors, such as P2X2, P2X4, and P2X7, can be activated
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by Mg2+-free ATP, but MgATP2 exhibits only low efficacy with
these receptors (Li et al., 2013).
The M2 site in the AmP2X structure is coupled with the ATP
binding site and bridges the receptor and the phosphate groups
of ATP (Figure 4B). The coordination of the divalent cation to the
b- and g-phosphate groups of the ATP in the M2 site is reminis-
cent of the MgATP2 complex. Furthermore, Asp188 in the M2
site is strictly conserved among the fast-desensitizing P2X1
and P2X3 receptors that exhibit similar sensitivities to both
MgATP2 and Mg2+-free ATP (Figure S1). Accordingly, we hy-
pothesized that the M2 site contributes to the accommodation
of the MgATP2 complex at the ATP binding site for the
MgATP2 sensitivity of these receptors.
To test our hypothesis on the functional role of the M2 site,
we performed an electrophysiological analysis with the human
P2X1 receptor, which exhibits similar sensitivities to both
MgATP2 and Mg2+-free ATP (Li et al., 2013). Because we
lack the structure of the P2X1 receptor and the Asp188 at the
M2 site in AmP2X, corresponding to Asp170 in P2X1, is located
on the loop region (Figure S1), we could not exclude the possi-
bilities that the neighboring Asp171 in P2X1 might be involved in
Mg2+ recognition or complement the mutation of Asp170.
Therefore, we introduced the mutations of both Asp170 and
neighboring Asp171 to create the mutant of human P2X1
(hD170A/hD171A) (the superscript ‘‘h’’ refers to human P2X1)
for the analysis of the M2 site. We analyzed the dose-response
relationships to ATP by the hWT and the hD170A/hD171A mutant
in the presence of high (5 mM) and low (0.5 mM) extracellular
Mg2+ concentrations (Figures 5C–5G). The hWT receptor ex-
hibited similar half-maximal effective concentration (EC50)
values for ATP at the high and low extracellular Mg2+ concentra-
tions, consistent with the previous electrophysiological report
(Figures 5C and 5D) (Li et al., 2013). In contrast, the
hD170A/hD171A mutant exhibited a 5-fold reduction in ATP
affinity at the high extracellular Mg2+ concentration (EC50 =
6.55 ± 1.44 mM) compared to that at the low extracellular
Mg2+ concentration (EC50 = 1.34 ± 0.27 mM) (Figures 5E and
5F). The rat P2X2 receptor, which lacks the M2 site (Figure S1),
also showed a Mg2+-dependent shift in the ATP concentration-
current amplitude relationship (Li et al., 2013). In addition, the
estimated log (Kd) value of the P2X2 receptor for Mg
2+ calcu-
lated from the shift was consistent with the known stability con-
stant of Mg2+ binding to ATP, indicating the strong preference
for Mg2+-free ATP over MgATP2. Overall, our results suggest
that the M2 site, which is coupled with the ATP binding site,
may contribute to the differential sensitivities to MgATP2
among subtypes of P2X receptors.Figure 3. Structural Comparisons of the Transmembrane Domains
(A–C) The transmembrane domains of apo, closed DP2X4-B2 (A); ATP-bound Am
surface model with a cartoon representation is shown for each structure. Amino
models. In (A) and (C), the distances between the Ca position of Ala347 and the c
distances between the Ca position of Val361 and the center of the pore are show
(D–F) Close-up views of the pore domain in apo, closed DP2X4-B2 (D); ATP-bound
(G–I) Pore radii for apo, closed DP2X4-B2 (G); ATP-bound AmP2Xcryst (H); and AT
(J–L) Close-up views of the TM2 helices in apo, closedDP2X4-B2 (J); ATP-bound A
pore constriction region are depicted by stick models.
(M–O) Cartoon models of the transmembrane regions in apo, closed DP2X4-B2 (
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In this work, we determined the crystal structure of the inverte-
brate P2X receptor from the Gulf Coast tick, in the presence of
ATP and Zn2+ ion, and identified two metal binding sites in the
extracellular domain of AmP2X to examine the divalent cation
modulation of P2X receptors.
The M1 site, located at the trimer interface, is responsible for
Zn2+ potentiation by allosterically facilitating the structural
change of the body domain in the extracellular region for pore
opening (Figures 4A–4D and 6). Zn2+ is an essential ion that
modulates numerous ion channels, such as NMDA receptors,
and is implicated in controlling their physiological functions
(Morris and Levenson, 2012). The M1 site is highly conserved
among the P2X4 receptors, and consistently, the Zn2+ modula-
tion of the P2X4 receptors may be involved in long-term poten-
tiation (Lorca et al., 2011), implying the physiological signifi-
cance of the M1 site among the P2X4 receptors. In the
phylogenetic tree, the invertebrate P2X receptors possessing
the M1 site are evolutionarily closer to each other than to the
invertebrate P2X receptors lacking the M1 site (Figure S2).
The invertebrate P2X receptors lacking the M1 site include
those from unicellular organisms, such as the marine green
alga Ostreococcus tauri and the soil amoeba Dictyostelium
discoideum (Figure S2). Furthermore, as we mentioned earlier,
the invertebrate P2X receptor, LsP2X from the great pond snail,
with the M1 site (Figure S1) is also reportedly potentiated
by Zn2+ ion (Bavan et al., 2012). These findings provide possible
insights into how P2X receptors evolutionally acquired the M1
site-mediated Zn2+ potentiation.
In contrast, the other divalent cation binding site, the M2 site,
is coupled with the ATP binding site and may contribute to
MgATP2 sensitivity among some P2X receptors (Figures 5C–
5G). Because ATP predominantly exists as MgATP2 in vivo,
it is reasonable that Mg2+ ion modulates the ATP-dependent re-
ceptor activation in a manner that is directly coupled with ATP
binding, rather than through allosteric modulation.
Overall, this work provides structural insights into the divalent
cation modulations of the P2X receptors, which form the basis
for the diverse physiological functions of this ion channel
superfamily.EXPERIMENTAL PROCEDURES
Expression and Purification
Expression screening of P2X orthologs and further construct optimization
were performed with GFP-FSEC and FSEC-based thermostability assayP2Xcryst (B); and ATP-bound DP2X4-C (C) viewed from the intracellular side. A
acid residues involved in the pore constriction region are depicted by stick
enter of the pore are shown by black lines and numbers (angstroms). In (B), the
n by black lines and numbers (angstroms).
AmP2Xcryst (E); and ATP-bound DP2X4-C (F) viewed parallel to the membrane.
P-bound DP2X4-C (I) along the pore center axis.
mP2Xcryst (K); and ATP-boundDP2X4-C (L). Amino acid residues involved in the
M); ATP-bound AmP2Xcryst (N); and ATP-bound DP2X4-C (O).
A B
C D
E
F G
Figure 4. Metal Binding Sites of AmP2X and of apo, Closed zfP2X4
(A) Overall view of the zinc binding sites in the AmP2X structure. The omit Fo  Fc map contoured at 6s, showing the electron densities of the zinc ions.
(B–D) Close-up views of the zinc binding sites. The anomalous difference Fourier maps contoured at 4s, showing the electron densities of the zinc ions.
(E) Overall view of the gadolinium binding site in the apo, closed zfP2X4 structure (PDB: 3H9V).
(F and G) Close-up view of the gadolinium binding site. The superscripts ‘‘zf,’’ ‘‘am,’’ and ‘‘h3’’ refer to zfP2X4, AmP2X, and human P2X3, respectively. The amino
acid residues zfGlu98 and zfAsp99 correspond to amGlu106 and amSer107 (h3Thr87), respectively.
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A B
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Figure 5. Zn2+ and Mg2+ Effects on the M1 and M2 Sites
(A) Representative currents of rat P2X4 (rWT) and the zinc binding site mutants evoked by 3 mM ATP in the presence and absence of 10 mM Zn2+.
(B) Accumulated data for the relative current amplitudes in the presence and absence of Zn2+. Bars depict mean + SEM (n = 5–7). The superscripts ‘‘r’’ and ‘‘am’’
refer to the rat P2X4 and AmP2X, respectively. The amino acid residues rGlu95 and rAsp170 correspond to amGlu106 and amAsp188, respectively.
(C–F) Effects of MgCl2 on the ATP-activated currents in human P2X1 WT (
hWT) and the hD170A/hD171A (amD188A/amY189A) mutant. (C and D) Representative
currents of hWT under the 5 mM MgCl2 conditions (C) and under the 0.5 mM MgCl2 conditions (D). (E and F) Representative currents of
hD170A/hD171A
(amD188A/amY189A) mutant under the 5 mMMgCl2 conditions (E) and under the 0.5 mMMgCl2 conditions (F). The numbers above the currents indicate the ATP
concentrations.
(G) Concentration-response relationships of ATP-evoked currents of hWT under the 5 mMMgCl2 conditions (EC50 = 1.65 ± 0.40 mM, n = 6) and under the 0.5 mM
MgCl2 conditions (EC50 = 1.14 ± 0.09 mM, n = 6) and of the
hD170A/hD171A (amD188A/amY189A) mutant under the 5mMMgCl2 conditions (EC50 = 6.55 ± 1.44 mM,
n = 7) and under the 0.5 mMMgCl2 conditions (EC50 = 1.34 ± 0.27 mM, n = 6). Error bars depict mean ± SEM. The superscripts ‘‘h’’ and ‘‘am’’ refer to the human
P2X1 and AmP2X, respectively. The amino acid residues hAsp170 and hAsp171 correspond to amAsp188 and amTyr189, respectively.(Hattori et al., 2012; Kawate and Gouaux, 2006). We found that the construct
(AmP2Xcryst) from AmP2X (Gene ID: 346469461) was biochemically robust and
suitable for crystallization.
The AmP2Xcryst construct was subcloned into the pEG BacMam vector, as
an N-terminal EGFP fusion with an octa-histidine affinity tag (EGFP-8 3 His),
and was expressed in HEK293S GnTI (N-acetylglucosaminyl-transferase
I-negative) cells (Goehring et al., 2014). Cell collection, disruption, and mem-
brane isolation were performed as described previously (Hattori and Gouaux,
2012), except for the use of Tris-buffered saline (TBS) (50 mM Tris [pH 8.0],
150 mM NaCl) supplemented with 5% glycerol. For the purification of
AmP2Xcryst, all buffers were supplemented with 5% glycerol. The membrane
fraction was solubilized for 1 hr in TBS, containing 40 mM n-dodecyl-b-D-
maltopyranoside (DDM) (Calbiochem). The detergent-soluble fraction was
incubated with Talon metal affinity resin (Clontech) and eluted with 250 mM
imidazole. After TEV protease digestion and Endo H treatment, to remove
the EGFP-8 3 His tag and part of the N glycans, the protein was isolated
by size-exclusion chromatography on a Superdex 200 10/300 GL column
(GE Healthcare) in size-exclusion chromatography buffer (20 mM HEPES
[pH 7.0], 100 mM NaCl) containing 5 mM n-decyl-b-D-maltopyranoside
(DM) (Anatrace). The peak fractions of the protein were collected and concen-
trated to 2 mg/ml using a centrifugal filter device (Millipore, 50 kDa molecular
weight cutoff).940 Cell Reports 14, 932–944, February 2, 2016 ª2016 The AuthorsCrystallization and Data Collection
Before crystallization, 1 mMATP was added to the protein solutions. The crys-
tals were grown at 4C with mixtures of 1:1 or 2:1 (v/v) ratios of protein and
reservoir solutions by the vapor diffusion method. The crystals of AmP2Xcryst
appeared in 8%–11% (w/v) PEG 8000, 0.05 M zinc acetate, and 0.05 M
MES (pH 6.0). The crystals were flash-frozen in liquid nitrogen for X-ray diffrac-
tion experiments. The X-ray diffraction data were collected at 100 K at BL41XU
of SPring-8 and were processed using HKL2000 (Otwinowski and Minor,
1997).
Structure Determination
The structure of AmP2Xcryst was obtained by molecular replacement with
Phaser (McCoy et al., 2007) using the ATP-bound DP2X4-C structure (PDB:
4DW1) as the template. The determined structure was further refined by using
the programs PHENIX (Afonine et al., 2012) and COOT (Emsley et al., 2010).
Crystallographic data and refinement statistics are presented in Table S1. All
figures were prepared with CueMol software (http://www.cuemol.org). In Fig-
ure 3, the pore plots were generated using HOLE software (Smart et al., 1996).
TEVC Recording
The Xenopus oocytes were incubated at 18C in Barth’s solution, containing
88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 10 mM HEPES, 0.33 mM
A B C
D E F
H
G
I
J
K L M
Figure 6. Zinc Modulation Mechanism
(A–C) Distributions of r (A), q (B), andf (C) are displayed. Orange distributions indicate the results of theMD simulations in the presence of Zn2+ at theM1 site, and
cyan distributions indicate the results of the MD simulations in the absence of Zn2+ at the M1 site.
(legend continued on next page)
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Ca(NO3)2, 0.41 mM CaCl2, and 0.82 mM MgSO4 (pH 7.4); supplemented with
50 mg/ml gentamicin; andwere used for recording after 4–7 days. The standard
bath solution for recordings contained 100 mM NaCl, 5 mM HEPES, 2 mM
MgCl2 (pH 7.3), and ATP and was freshly prepared each day. In Figures 5C–
5G, the sensitivity to MgATP2 was analyzed with two recording solutions,
containing 100 mM NaCl, 5 mM HEPES (pH 7.3), and either 5 mM or 0.5 mM
MgCl2. Under these conditions, [MgATP
2] and [Mg2+-free ATP] increase line-
arly with increasing [ATP] applied. [Mg2+-free ATP] in the high (5 mM) Mg2+ so-
lution is about eight or nine times lower than that in the low (0.5 mM) Mg2+ so-
lution, while [MgATP2] is exactly the same between the two solutions. Hence,
the difference in the ATP dose response is considered to be derived from the
reduction of the MgATP2 binding to the mutant channel (Figure 5G). A small
amount of divalent cation was needed to suppress the endogenous currents of
the oocytes, and 0.5 mM MgCl2 was sufficient in this experiment. Oocytes
were held at 70 mV with a bath-clamp amplifier (OC-725C, Warner) with
the direct current gain booster turned on, and the macroscopic currents
were recorded and analyzed using pClamp 10 software (Molecular Devices),
as described previously (Fujiwara et al., 2009). Actual clamped membrane po-
tentials were also monitored during the recordings, and data with an error of
more than 1 mV from the command potentials were discarded. When the
data were contaminated by endogenous currents and/or leak currents, they
were also discarded. In Figures 5A and 5B, the ratios of the current amplitudes
in the presence or absence of ZnCl2 to the amplitude before Zn
2+ application
were analyzed. In Figures S5A–S5D, a dataset from an identical oocyte
was used for the analysis of the half-maximal inhibitory concentration value
for GdCl3.
Confocal Microscopy
The hemagglutinin-tagged, EGFP-fused AmP2X WT and mutants were in-
jected in oocytes. At 3–4 days after injection, the oocytes were imaged using
an FV300 confocal microscope (Olympus) equipped with a320/0.5 numerical
aperture objective under TEVC. The bath solution was the same as that used
for the TEVC recordings (see TEVC Recording). Images were collected every
30 s for 25 min using the Fluoview software (Olympus). Fluorescence intensity
was calculated for each image and plotted against time, and the data were re-
ported as mean ± SEM (Figure S3).
Radiolabeled ATP Binding Experiments
The EGFP-fusion AmP2Xcryst construct was expressed and purified as
described previously; concentrated; dialyzed overnight at 4C to remove im-
purities in dialysis buffer containing 20 mM HEPES (pH 7.0), 100 mM NaCl,
5% glycerol, and 1 mM DDM; and stored at 80C before use. ATP binding
experiments were performed in the same manner as described previously
(Hattori and Gouaux, 2012), except for the use of dialysis buffer containing
20 mM HEPES (pH 7.0), 80 mM NaCl, 20 mM KCl, 1 mM DDM, and 1,000–
3,000 nM 3H-ATP (PerkinElmer), in which the radiolabeled ATP was diluted
with unlabeled ATP at a ratio of 1:4. The entire experiment was performed in
triplicate. Data were fit to a sigmoidal dose-response equation.
MD Simulations
The simulation system included the AmP2Xcryst trimer, 1-palmitoyl-2-oleoyl-
phosphatidylcholine (POPC), ATP, Zn2+ ions, water molecules, and 150 mM
NaCl. The missing atoms, including hydrogens in the protein, were added
with the program VMD (Humphrey et al., 1996). The periodic boundary system,(D and E) The transmembrane domain of ATP-bound AmP2Xcryst after the 150 ns
Zn2+ at the M1 site (E). Each structure is viewed from the extracellular side. A sur
(F) The time course of the pore sizes of ATP-bound AmP2Xcryst through the 150 n
presence of Zn2+ at the M1 site, and the cyan graph shows the results of the simu
triangular dimensions formed by the three Ca positions of Val362 from each sub
(G–J) Subunit comparisons of ATP-bound AmP2Xcryst before the MD simulation (g
(orange) and in the absence of Zn2+ at the M1 sites (cyan). Close-up views of the
(K–M) Cartoon models of the Zn2+-dependent stabilization mechanism of the ATP
the absence of Zn2+ at theM1 site. (L) The crystal structuremodel of ATP, Zn2+-bou
Zn2+ at the M1 site. In cartoon models (K) and (M), the black arrows denote the m
942 Cell Reports 14, 932–944, February 2, 2016 ª2016 The Authorsincluding the explicit solvent and the POPC lipid bilayer, was prepared. The
size of the simulation box was 128 3 128 3 148 A˚. The net charge of the sys-
tem was neutralized by adding chloride and sodium ions. The topologies and
force field parameters from CHARMM36 were used (Klauda et al., 2010). MD
simulations were performed with the program NAMD 2.9 (Phillips et al., 2005).
The system was first energy minimized for 1,000 steps with fixed positions for
the non-hydrogen atoms and then for another 1,000 steps with 10 kcal/mol re-
straints for the non-hydrogen atoms. Next, we performed an equilibration run
for 0.5 ns in the NVT ensemble (310 K, 1283 1283 148 A˚ volume) with 10 kcal/
mol restraints for protein non-hydrogen atoms, ATP, and Zn2+, followed by an
equilibration run for 1.0 ns in the NPT ensemble (310 K, 1 atm), with the same
restraints. Finally, we performed equilibration runs for 1.0 ns in the NPT
ensemble, with the bond length restraints between Zn2+ ions or ATP and the
protein side chain: (1) ATP N1 and Thr206 OG1, (2) M2 and ATP OG1, (3) M1
and Glu105, (4) M1 and Glu106, and (5) M2 and Asp188 of the adjacent chain.
These restrained bond lengths are based on those observed in the crystal
structure of AmP2Xcryst. The production process was performed for 150 ns,
with the same bond length restraints. Constant temperature was maintained
by using Langevin dynamics. Constant pressure was maintained by using
the Langevin piston Nose´-Hoover method (Feller et al., 1995). Long-range
electrostatic interactions were calculated using the particle mesh Ewald
method (Darden et al., 1993).
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